Page 1495 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 83 Virus-Associated Lymphoma 1329.e1

REFERENCES 24. Evens AM, Roy R, Sterrenberg D, et al: Post-transplantation lympho-
proliferative disorders: diagnosis, prognosis, and current approaches to
1. Cohen JI: Epstein-Barr virus infection. N Engl J Med 343:481, 2000. therapy. Curr Oncol Rep 12:383, 2010.
2. Thorley-Lawson DA, Gross A: Persistence of the Epstein-Barr virus and 25. Murray PG, Deacon E, Young LS, et al: Localization of Epstein-Barr
the origins of associated lymphomas. N Engl J Med 350:1328, 2004. virus in Castleman’s disease by in situ hybridization and immunohisto-
3. Savoldo B, Goss JA, Hammer MM, et al: Treatment of solid organ chemistry. Hematol Pathol 9:17, 1995.
transplant recipients with autologous Epstein Barr virus-specific cyto- 26. Heslop HE, Slobod KS, Pule MA, et al: Long-term outcome of EBV-
toxic T lymphocytes (CTLs). Blood 108:2942, 2006. specific T-cell infusions to prevent or treat EBV-related lymphoprolif-
4. Roughan JE, Torgbor C, Thorley-Lawson DA: Germinal center B cells erative disease in transplant recipients. Blood 115:925, 2010.
latently infected with Epstein-Barr virus proliferate extensively but do 27. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al: Increased inci-
not increase in number. J Virol 84:1158, 2010. dence of lymphoproliferative disorder after immunosuppression with
5. Mainou BA, Raab-Traub N: LMP1 strain variants: biological and the monoclonal antibody OKT3 in cardiac-transplant recipients. N
molecular properties. J Virol 80:6458, 2006. Engl J Med 323:1723, 1990.
6. Vereide DT, Sugden B: Lymphomas differ in their dependence on 28. Ashrafi F, Shahidi S, Ebrahimi Z, et al: Outcome of rapamycin therapy
Epstein-Barr virus. Blood 117:1977, 2011. for post-transplant-lymphoproliferative disorder after kidney transplan-
7. Epeldegui M, Hung YP, McQuay A, et al: Infection of human tation: case series. Int J Hematol Oncol Stem Cell Res 9:26, 2015.
B cells with Epstein-Barr virus results in the expression of somatic 29. Glaser SL, Lin RJ, Stewart SL, et al: Epstein-Barr virus-associated
hypermutation-inducing molecules and in the accrual of oncogene Hodgkin’s disease: epidemiologic characteristics in international data.
mutations. Mol Immunol 44:934, 2007. Int J Cancer 70:375, 1997.
8. Rovedo M, Longnecker R: Epstein-Barr virus latent membrane protein 30. Keegan TH, Glaser SL, Clarke CA, et al: Epstein-Barr virus as a marker
2A preferentially signals through the Src family kinase Lyn. J Virol of survival after Hodgkin’s lymphoma: a population-based study. J Clin
82:8520, 2008. Oncol 23:7604, 2005.
9. Williams H, Crawford DH: Epstein-Barr virus: the impact of scientific 31. Hjalgrim H, Askling J, Rostgaard K, et al: Characteristics of Hodgkin’s
advances on clinical practice. Blood 107:862, 2006. lymphoma after infectious mononucleosis. N Engl J Med 349:1324,
10. Higgins CD, Swerdlow AJ, Macsween KF, et al: A study of risk factors 2003.
for acquisition of Epstein-Barr virus and its subtypes. J Infect Dis 32. Ambinder RF, Browning PJ, Lorenzana I, et al: Epstein-Barr virus and
195:474, 2007. childhood Hodgkin’s disease in Honduras and the United States. Blood
11. Tierney RJ, Edwards RH, Sitki-Green D, et al: Multiple Epstein-Barr 81:462, 1993.
virus strains in patients with infectious mononucleosis: comparison of 33. Glaser SL, Gulley ML, Clarke CA, et al: Racial/ethnic variation in
ex vivo samples with in vitro isolates by use of heteroduplex tracking EBV-positive classical Hodgkin lymphoma in California populations.
assays. J Infect Dis 193:287, 2006. Int J Cancer 123:1499, 2008.
12. Glaser SL, Gulley ML, Borowitz MJ, et al: Inter- and intra-observer 34. Glaser SL, Clarke CA, Gulley ML, et al: Population-based patterns
reliability of Epstein-Barr virus detection in Hodgkin lymphoma using of human immunodeficiency virus-related Hodgkin lymphoma in the
histochemical procedures. Leuk Lymphoma 45:489, 2004. Greater San Francisco Bay Area, 1988-1998. Cancer 98:300, 2003.
13. Hsieh PP, Tung CL, Chan AB, et al: EBV viral load in tumor tissue is 35. Siebert JD, Ambinder RF, Napoli VM, et al: Human immunodeficiency
an important prognostic indicator for nasal NK/T-cell lymphoma. Am virus-associated Hodgkin’s disease contains latent, not replicative,
J Clin Pathol 128:579, 2007. Epstein-Barr virus. Hum Pathol 26:1191, 1995.
14. MacMahon EM, Glass JD, Hayward SD, et al: Epstein-Barr virus 36. Kanakry JA, Li H, Gellert LL, et al: Plasma Epstein-Barr virus DNA
in AIDS-related primary central nervous system lymphoma. Lancet predicts outcome in advanced Hodgkin lymphoma: correlative analysis
338:969, 1991. from a large North American cooperative group trial. Blood 121:3547,
15. Campo E, Swerdlow SH, Harris NL, et al: The 2008 WHO clas- 2013.
sification of lymphoid neoplasms and beyond: evolving concepts and 37. Gandhi MK, Lambley E, Burrows J, et al: Plasma Epstein-Barr virus
practical applications. Blood 117:5019, 2011. (EBV) DNA is a biomarker for EBV-positive Hodgkin’s lymphoma.
16. Carbone A, Cesarman E, Spina M, et al: HIV-associated lymphomas Clin Cancer Res 12:460, 2006.
and gamma-herpesviruses. Blood 113:1213, 2009. 38. Spacek M, Hubacek P, Markova J, et al: Plasma EBV-DNA monitoring
17. Huppmann AR, Nicolae A, Slack GW, et al: EBV may be expressed in in Epstein-Barr virus-positive Hodgkin lymphoma patients. APMIS
the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma 119:10, 2011.
(NLPHL) in both children and adults. Am J Surg Pathol 38:316, 2014. 39. Bollard CM, Gottschalk S, Torrano V, et al: Sustained complete
18. Bennett JA, Bayerl MG: Epstein-Barr virus-associated extranodal responses in patients with lymphoma receiving autologous cytotoxic
marginal zone lymphoma of mucosa-associated lymphoid tissue T lymphocytes targeting Epstein-Barr virus latent membrane proteins.
(MALT lymphoma) arising in the parotid gland of a child with ataxia J Clin Oncol 32:798, 2014.
telangiectasia. J Pediatr Hematol Oncol 37:e114, 2015. 40. Kelly GL, Rickinson AB: Burkitt lymphoma: revisiting the pathogenesis
19. Nassif S, Ozdemirli M: EBV-positive low-grade marginal zone lym- of a virus-associated malignancy. Hematology Am Soc Hematol Educ
phoma in the breast with massive amyloid deposition arising in a Program 2007:277, 2007.
heart transplant patient: a report of an unusual case. Pediatr Transplant 41. Moore PS, Chang Y: KSHV: forgotten but not gone. Blood 117:6973,
17:E141, 2013. 2011.
20. Gibson SE, Swerdlow SH, Craig FE, et al: EBV-positive extranodal 42. Ambinder RF, Cesarman E: Clinical and pathological aspects of EBV
marginal zone lymphoma of mucosa-associated lymphoid tissue in the and KSHV infection. In Arvin AM, Campadelli-Fiume G, Mocarski
posttransplant setting: a distinct type of posttransplant lymphoprolif- ES, et al, editors: Human herpesviruses: biology, therapy, and immuno-
erative disorder? Am J Surg Pathol 35:807, 2011. prophylaxis, Cambridge, UK, 2007, Cambridge University Press.
21. Tsimberidou AM, O’Brien S, Kantarjian HM, et al: Hodgkin transfor- 43. Courville EL, Sohani AR, Hasserjian RP, et al: Diverse clinicopatho-
mation of chronic lymphocytic leukemia: the M.D. Anderson Cancer logic features in human herpesvirus 8-associated lymphomas lead to
Center experience. Cancer 107:1294, 2006. diagnostic problems. Am J Clin Pathol 142:816, 2014.
22. Nicolae A, Pittaluga S, Venkataraman G, et al: Peripheral T-cell 44. Du MQ, Diss TC, Liu H, et al: KSHV- and EBV-associated germino-
lymphomas of follicular T-helper cell derivation with Hodgkin/Reed- tropic lymphoproliferative disorder. Blood 100:3415, 2002.
Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative 45. Yates JA, Zakai NA, Griffith RC, et al: Multicentric Castleman disease,
variants exist. Am J Surg Pathol 37:816, 2013. Kaposi sarcoma, hemophagocytic syndrome, and a novel HHV8-
23. Huang J, Zhang PH, Gao YH, et al: Sequential development of diffuse lymphoproliferative disorder. AIDS Read 17:596, 2007.
large B-cell lymphoma in a patient with angioimmunoblastic T-cell 46. Sasaki Y, Isegawa T, Shimabukuro A, et al: Primary effusion lymphoma
lymphoma. Diagn Cytopathol 40:346, 2012. in an elderly HIV-negative patient with hemodialysis: importance of